There were significant differences, however, in Rb phosphorylation when comparing sensitive and resistant cells after exposure to the compound.
By comparing sensitive and resistant tumors, a gene "top scoring" pair leucine rich repeat containing protein 19 (LRRC19) gene expression > insulin-like growth factor-binding protein 2 (Igene2) gexpressionsion achieved high accuracy in predicting sensitivity preclinically [ 17].
We aimed to compare the sensitive and quality-controlled KRAS testing with direct sequencing and to assess the impact on decision making of treatment.
‡As in previous tables sensitivity groups are compared with sensitive group given antibiotics as comparison group.
Although more genes were differentially expressed in sensitive (410) than tolerant accessions (99), more GO categories were enriched in tolerant compared with sensitive accessions.
This can be seen by comparing the sensitive Loess trendline to a simple linear trendline, as in the following chart.
This tolerant strain also showed higher ethanol productivity, biomass formation and alcohol dehydrogenase activity comparing to sensitive strains.
As revealed by studies from the Massachusetts General Hospital, 5 out of 9 resistant patient samples have EGFR activation compared to sensitive samples.
Aβ resistant cells showed higher levels of LDHA activity and also generated higher levels of lactic acid compared to sensitive cells.
